1-11 of 11
Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Close
Sort by
Articles

Deciphering the Dilemmas Posed by Detection of Mutant Myeloid Clones

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2018) 16 (1)
https://doi.org/10.1182/hem.V16.1.9299
Published: 2018
Articles

Acquired Clinical Resistance to IDH2 Inhibitors: Leukemia Finds Multiple Avenues for Escape

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2018) 15 (6)
https://doi.org/10.1182/hem.V15.6.9020
Published: 2018
Articles

Not All Large Cells Are Created Equal: Is Genomic Classification the New Frontier in Diffuse Large B-cell Lymphoma?

Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2018) 15 (5)
https://doi.org/10.1182/hem.V15.5.8883
Published: 2018
Articles

Targeted Therapy to Trigger GVL: A Case for the Prosecution in FLT3-ITD–Mutant AML

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2018) 15 (3)
https://doi.org/10.1182/hem.V15.3.8469
Published: 2018
Articles

Complexity of DNA Repair From Alcohol Damage Revealed

Edward Chew, MBBS, Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2018) 15 (2)
https://doi.org/10.1182/hem.V15.2.8291
Published: 2018
Articles

Lighting the Path to Personalized Medicine for Hematologic Malignancies: Lessons From an AML Knowledge Bank

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 15 (1)
https://doi.org/10.1182/hem.V15.1.8121
Published: 2017
Articles

A Randomized Trial in a Rare Cancer: Targeting CD30 in Cutaneous T Cell Lymphoma Yields Therapeutic Dividends

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 14 (6)
https://doi.org/10.1182/hem.V14.6.7793
Published: 2017
Articles

CHIP and Coronary Heart Disease: Clonal Hematopoiesis Increases Atherosclerosis

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 14 (5)
https://doi.org/10.1182/hem.V14.5.7618
Published: 2017
Articles

Can Chemoimmunotherapy Be Improved As Front-Line Therapy for CLL in Fit Patients?

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 14 (4)
https://doi.org/10.1182/hem.V14.4.7473
Published: 2017
Articles

Stopping Imatinib in CML: Safe in the Long Term for Deep Molecular Responders As the Immune System Steps Up

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 14 (3)
https://doi.org/10.1182/hem.V14.3.7261
Published: 2017
Articles

Relapsed CLL: A Problem, Not Yet Solved

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 14 (2)
https://doi.org/10.1182/hem.V14.2.7136
Published: 2017